Conversion study of hepatocellular carcinoma using HAIC combined with lenvatinib and PD-1/L1 immunotherapy under the guidance of BCLC staging by Weihao Zhang, Weihao Zhang, Weihao Zhang, Xiaohui Zhao, Xiaohui Zhao, Xiaohui Zhao, Wei Gao, Wei Gao, Wei Gao, Tongguo Si, Tongguo Si, Tongguo Si, Qiang Zou, Qiang Zou, Qiang Zou, Xueling Yang, Xueling Yang, Xueling Yang, Wenge Xing, Wenge Xing, Wenge Xing, Haipeng Yu, Haipeng Yu, Haipeng Yu

Get full text